Biotech

All Articles

Pfizer, Valneva show lyme health condition shot reliable for 2nd enhancer

.Pfizer as well as Valneva may possess regarding 2 more years to hang around just before they make t...

Fierce Biotech Managing Editor Ayla Ellison Talks Shop with Michelle Benz on the Future of Biotech.

.Let's study a talk with Ayla Ellison, Brutal Biotech Managing Editor as well as Michelle Benz as th...

New information show how Bayer's asundexian fell short to stop strokes

.Bayer put on hold the period 3 trial for its factor XIa prevention asundexian late last year after ...

Sanofi's tolebrutinib falls short 2 of 3 late-stage MS trials

.Sanofi is actually still set on taking its own a number of sclerosis (MS) med tolebrutinib to the F...

Galapagos' stock up as fund shows intent to shape its own progression

.Galapagos is actually coming under added stress from entrepreneurs. Having built a 9.9% stake in Ga...

Cell- focused Sana scoops 1st CSO-- Chutes &amp Ladders

.Welcome to this week's Chutes &amp Ladders, our roundup of significant management hirings, firings ...

Allist pays Jacobio $21M, landing job in Chinese KRAS race

.Shanghai Allist Pharmaceuticals has actually purchased on its own a starring job in China's KRAS ma...

ReNeuron leaving behind goal exchange after missing fundraising target

.ReNeuron has actually participated in the long list of biotechs to leave Greater london's objective...

MBX declare IPO to take challenger to Ascendis into stage 3

.MBX Biosciences has contributed to the recent outbreak of IPO filings. The biotech, which filed its...

FDA broadens probe into Lykos' MDMA trials: WSJ

.For Lykos Therapeutics as well as the provider's prospective MDMA-assisted therapy for trauma (POST...